News – Page 58 – Endpoints News

Immunovant’s $450M private placement; Biomea becomes an obesity biotech

4 months ago

Hengrui and Kailera’s injected incretin posts best-in-class obesity data in Phase 2 trial

4 months ago

Normunity nabs $75M Series B to advance T cell engager and launch first trial

4 months ago

Aragen gets $100M from private equity firm to expand manufacturing footprint

4 months ago

Lilly to acquire cancer biotech Scorpion, which shares a co-founder with Loxo

4 months ago

AstraZeneca, CRISPR tools supplier ink gene editing enzyme licensing deal

4 months ago

Updated: J&J to buy Intra-Cellular for $14.6B in latest neuroscience bet

4 months ago

#JPM25 live blog day 1: How will Trump 2.0 impact the biopharma industry? Scott Gottlieb, Bob Nelsen share ...

4 months ago

Gilead taps into STAT6 space via $250M deal with Leo Pharma

4 months ago

Regor’s obesity pill posts muted weight loss in Phase 2a, enters new trial

4 months ago

Bayer’s BlueRock now plans to bring Parkinson’s cell therapy straight to Phase 3 trial

4 months ago

GSK kicks off JPM dealmaking with $1B+ buyout of IDRx and its rare cancer drug

4 months ago

Lantheus to buy Life Molecular Imaging for $350M, netting Alzheimer's diagnostic

4 months ago

J&J looks at potential bid for Intra-Cellular — report

4 months ago

Post-Hoc: The embryo editing debate is back

4 months ago

Exclusive: Bucking gene editing downturn, Tune raises $175M to bring epigenetic editing to clinic

4 months ago

Post-Hoc: Big Pharma is losing the AI talent war

4 months ago

DNA edit leads to apparent cure in infant; CDER director to step down; More biotechs emerge with assets from China; ...

4 months ago

Biogen offers to buy out struggling neuro partner Sage Therapeutics

4 months ago

Chasing the next wave of obesity drugs, Metsera files for an IPO

4 months ago

FDA adcomm votes to support Seikagaku's herniated disc injection

4 months ago

Lawmakers ask Biden administration to tighten rules around China clinical trials

4 months ago

Pfizer touts bladder cancer results as first advancement for some patients 'in decades'

4 months ago

Lilly finances new $500M biotech fund managed by a16z

4 months ago

First page Previous page 55 56 575859 60 61 Next page Last page